Background
==========

Ovarian teratoma (dermoid cyst) is a benign tumor originating in germ cells. This tumor is one of the most common germ cell tumors and accounts for up to 20% of all ovarian cysts \[[@B1]\]. Ovarian teratoma is the most common tumor associated with pregnancy \[[@B2]\]. Generally, ovarian teratomas are cured by a complete surgical resection; however, some cases could give rise to a malignant disease \[[@B3],[@B4]\]. Ovarian teratomas could be of both homozygous and heterozygous origin, as well as the mixture of the two, and it has been previously suggested that several mechanisms could lead to their development, including failure of meiosis I, failure of meiosis II, or duplication of a mature ovum \[[@B5]\]. Mature ovarian teratomas often contain a mixture of fully differentiated tissues from all three cell layers, ectodermal, endodermal, and mesodermal, resulting in formation of skin, hair follicle, sebaceous gland, bone, teeth, thyroid, and other cell types \[[@B6],[@B7]\].

Our previous data obtained using a limited number of subjects suggested that a chemokine receptor fractalkine (CX~3~CR1) is expressed in ovarian teratomas \[[@B8]\]. CX~3~CR1 is a G protein-coupled receptor with multiple functions in both the normal state and disease \[[@B9],[@B10]\]. CX~3~CR1 is activated by its highly specific ligand fractalkine (CX~3~CL1) \[[@B11]\]. It has been shown that CX~3~CL1/CX~3~CR1 axis plays a role in differentiation of osteoclasts \[[@B12]\] and development of dendritic cells \[[@B13]\], but its role in skin differentiation has not been described.

The goal of this study was to determine the predominant type of CX~3~CR1-positive cells in ovarian teratomas. We also aimed to determine whether the same cell type(s) are CX~3~CR1-positive during the normal development. Lastly, using a cell culture model, we intended to establish whether CX~3~CR1 expression is required for cell differentiation.

Methods
=======

Materials
---------

Tissue microarray (TMA) slides containing specimens of ovarian teratoma (Cat\# OV805) and specimens of human fetal tissues (Cat\# BE01014) were obtained from US Biomax (Rockville, MD). Because these specimens were commercially available and were deidentified, no approvals by the Institutional Review Board were required. GFP-tagged CX~3~CR1 shRNA and scrambled shRNA constructs were obtained from Origene Technologies (Rockville, MD). DharmaFECT was obtained from Dharmacon (Lafayette, CO). Matrigel was obtained from BD Biosciences (Bedford, MA). Mouse monoclonal CK14 and CK18 and rabbit polyclonal CX~3~CR1 (Cat\# ab49747, ab49824, ab8021 and ab8020, respectively) antibodies were obtained from Abcam (Cambridge, MA), and mouse monoclonal β-tubulin antibody was obtained from Developmental Studies Hybridoma Bank (Iowa City, IA), goat polyclonal CX~3~CL1 (Cat\# AF365) was purchased from R&D systems (Minneapolis, MN), and mouse monoclonal actin antibody was purchased from Santa Cruz Biotechnology (Dallas, TX). Vectastain ABC and DAB kits were obtained from Vector Laboratories (Burlingame, CA). BMP-4 was purchased from Invitrogen (Carlsbad, CA).

Cell culture and directed differentiation
-----------------------------------------

Ovarian teratocarcinoma cell line PA-1 and ovarian carcinoma cell line SKOV-3 were obtained from American Tissue Culture Collection (Manassas, VA). PA-1 cells were plated on Matrigel-coated (at 1/100 dilution) tissue culture plates or glass cover slips at 5% confluence and cultured in minimal essential media supplemented with sodium pyruvate and non-essential amino acids for 2 weeks. Cells subjected to differentiation into skin lineage were cultured in the above described media containing 10 μg/ml BMP-4.

Immunohistochemical staining
----------------------------

TMA slides were deparaffinized by baking at 60°C for 2 h and rehydrated by incubation in xylene, 100% ethanol, 95% ethanol, 70% ethanol, and phosphate buffered saline, pH 7.4, for 5 min each. Peroxidase activity was inhibited with hydrogen peroxide. Antigen retrieval was performed by 15 min incubation in 1 mM ethylene diamine tetraacetic acid (EDTA; pH 8.0) at 95°C. Prior to primary antibody staining (1:50 dilution, rabbit anti-human CX~3~CR1, Abcam Cat\# ab8021, 1 h at room temperature (RT)) non-specific binding was blocked by incubation with 10% goat serum for 1 h. The biotin-conjugated goat anti-rabbit secondary antibody was used at a 1:200 dilution for 30 min at RT. The Vectashield ABC kit was used as directed by the manufacturer, and tissues were incubated for 45 min at RT. The DAB reagent was prepared as instructed by the manufacturer and applied to tissues on TMA slides for 2 -- 10 min until brown color developed. TMAs were stained with hematoxylin, dehydrated in 50%, 70%, 95%, and 100% ethanol, and mounted with Permount. Pancreatic cancer tissue was used as a positive control. Staining was evaluated by A.K.-B. and L.R., who were both blinded to the experimental outcomes of the study. Staining was scored based on the intensity and percentage of positive cells. Intensity of staining was "0" for negative samples, "1" for weakly positive samples, "2" for moderately positive samples, and "3" for highly positive samples. Overall scores were derived as the intensity score multiplied by the percentage. Staining was assessed separately in the cytoplasm and the membrane.

Cell transfection and generation of stable cell lines
-----------------------------------------------------

PA-1 cells were cultured to 80% confluence and transfected with either CX~3~CR1-specific GFP-tagged shRNA construct or scrambled GFP-tagged shRNA construct (Origene Technologies) using DharmaFECT according to the manufacturer's instructions. Selection of the clones was performed with puromycin and green fluorescence as suggested by the manufacturer.

Immunofluorescence staining
---------------------------

Cells were cultured on glass coverslips to 50-70% confluence, fixed, permeabilized with 0.01% Triton X-100, and blocked in goat serum. Mouse monoclonal CK-14 (Cat\# ab49747) antibody was used at a dilution of 1:50. Cells were incubated with the primary antibodies for 1 h at room temperature (22°C). The cells were then incubated with secondary Alexa555-conjugated anti-mouse antibodies (1:500) for 1 h at RT in the dark. 4',6-Diamidino-2-phenylindole (DAPI) was added to the secondary antibody solution to a final concentration of 10 μg/ml 10 min prior to the end of the incubation period. Cells were washed, air dried, and mounted on glass slides using ProlongGold (Invitrogen, Carlsbad, CA). Fluorescent imaging was performed using a Zeiss AxioObserverD.1 fluorescent microscope.

Western blotting
----------------

Western blotting analysis was used to detect the expression of CK14, CK18, CX~3~CR1, CX~3~CL1, actin, and β-tubulin in PA-1. This procedure was performed as previously described \[[@B8],[@B14],[@B15]\] Antibodies were used at the following dilutions: 1:500 mouse anti-human-CK14 or CK18, or CX~3~CL1, rabbit anti-human CX~3~CR1 (Abcam ab8020) and 1:200 mouse anti-human-β-tubulin or goat anti-human actin in 3% BSA in a solution of 50 mM tris-buffered saline, pH 7.4, 150 mM NaCl, and 0.05% Tween-20 (TBST). Immunoreactive bands were visualized with anti-(mouse-IgG)-peroxidase, anti-(goat-IgG)-peroxidase, and anti-(rabbit-IgG)-peroxidase (Sigma, St. Louis, MO) (1:1000 in 3% BSA in TBST), and enhanced chemiluminescence was read using Chemidoc (Bio-Rad) and Bio-Rad Chemidoc ImageReader software.

Results
=======

CX~3~CR1 is expressed in specimens of ovarian teratoma
------------------------------------------------------

According to our previous observations CX~3~CR1 was expressed in cells comprising ovarian teratoma tissue specimens \[[@B8]\], although the number of specimens was very limited in order to be able to draw any conclusions. In the present study we aimed to expand this observation on a larger number of ovarian teratoma specimens and determine the predominant cell type(s) positive for CX~3~CR1. Thus, we tested expression of CX~3~CR1 using a tissue microarray containing 68 specimens of mature ovarian teratoma, 10 specimens of immature teratoma, and 2 cases of monodermal teratoma. Interestingly, we have found that skin keratinocytes represent the most predominant CX~3~CR1-positive cell type, which was present in 38% of tested cases of mature ovarian teratoma (Table [1](#T1){ref-type="table"}, Figure [1](#F1){ref-type="fig"}). The next most common CX~3~CR1-positive types of cells in the tested cases of dermoid cyst were those comprising the pilosebaceous unit of the skin assembled of sebaceous gland and hair follicle (Table [1](#T1){ref-type="table"}, Figure [1](#F1){ref-type="fig"}). Other CX~3~CR1-positive cell types in the order of diminution included lymphatic, apocrine, adipose, thyroid, respiratory epithelial, peripheral nervous, endothelial, and eccrine (Table [1](#T1){ref-type="table"}). Cases of tested immature ovarian teratoma were characterized by the presence of CX~3~CR1-positive brain, lymphatic, respiratory epithelial, adipose, and sebaceous cells (Table [1](#T1){ref-type="table"}). Two tested monodermal teratomas consisted of CX~3~CR1-positive thyroid and lymphatic tissues, respectively (Table [1](#T1){ref-type="table"}). Thus, our data suggest that skin keratinocytes are the predominant type of CX~3~CR1-positive cells in the tested specimens of mature ovarian teratomas.

![**CX**~**3**~**CR1 is expressed in human ovarian teratoma.** Specimens of ovarian teratoma were examined for CX~3~CR1 expression by immunohistochemistry. Brown -- CX~3~CR1; blue -- hematoxylin. Images were generated using an Aperio ScanScope digital slide scanner. Magnification -- 5×. A region outlined by a dotted line is shown at 20× magnification. Cells of the sebaceous gland, hair follicle, and skin are indicated.](1757-2215-6-57-1){#F1}

###### 

Expression of CX3CR1 in human specimens of ovarian teratoma

   **Position**   **Number**   **Sex**   **Age**   **Organ**           **Pathology**            **Grade**   **Type**       **Tissue type**       **Intensity\***   **Location\*\***   **Percentage\*\*\***
  -------------- ------------ --------- --------- ----------- -------------------------------- ----------- ----------- ------------------------ ----------------- ------------------ ----------------------
        A1            1           F        28        Ovary            Mature teratoma              \-        Benign           Sebaceous                2.5                C                   100
        A1            1           F        28        Ovary            Mature teratoma              \-        Benign            Apocrine                 1                 C                    10
        A2            2           F        24        Ovary            Mature teratoma              \-        Benign              Skin                   2                 C                    20
        A2            2           F        24        Ovary            Mature teratoma              \-        Benign          Lymphocytes                3                 N                    90
        A3            3           F        26        Ovary            Mature teratoma              \-        Benign               NR                                                            
        A4            4           F        33        Ovary            Mature teratoma              \-        Benign              Skin                   3                 C                   100
        A4            4           F        33        Ovary            Mature teratoma              \-        Benign           Sebaceous                 3                 C                   100
        A5            5           F        48        Ovary            Mature teratoma              \-        Benign            Follicle                 3                 C                   100
        A6            6           F        19        Ovary            Mature teratoma              \-        Benign              Skin                   3                 C                   100
        A6            6           F        19        Ovary            Mature teratoma              \-        Benign          Endothelium               1.5                C                    90
        A7            7           F        52        Ovary            Mature teratoma              \-        Benign              Skin                  2.5                C                   100
        A7            7           F        52        Ovary            Mature teratoma              \-        Benign           Sebaceous                2.5                C                   100
        A8            8           F        27        Ovary            Mature teratoma              \-        Benign              Skin                   2                 C                   100
        A8            8           F        27        Ovary            Mature teratoma              \-        Benign            Apocrine                 3                 C                   100
        A8            8           F        27        Ovary            Mature teratoma              \-        Benign             Lymph                   3                 NM                   50
        A9            9           F        22        Ovary            Mature teratoma              \-        Benign           Sebaceous                 3                 C                   100
       A10            10          F        54        Ovary            Mature teratoma              \-        Benign              Skin                   2                 C                   100
       A10            10          F        54        Ovary            Mature teratoma              \-        Benign           Sebaceous                2.5                C                   100
        B1            11          F        58        Ovary            Mature teratoma              \-        Benign            Adipose                  1                 C                    80
        B1            11          F        58        Ovary            Mature teratoma              \-        Benign            Adipose                  3                 M                    40
        B2            12          F        32        Ovary            Mature teratoma              \-        Benign              Skin                   2                 C                   100
        B2            12          F        32        Ovary            Mature teratoma              \-        Benign            Follicle                2.5                C                   100
        B2            12          F        32        Ovary            Mature teratoma              \-        Benign           Sebaceous                 3                 C                   100
        B3            13          F        28        Ovary            Mature teratoma              \-        Benign               NR                                                            
        B4            14          F        40        Ovary            Mature teratoma              \-        Benign            Adipose                  1                 C                    60
        B4            14          F        40        Ovary            Mature teratoma              \-        Benign            Adipose                  3                 M                    40
        B5            15          F        26        Ovary            Mature teratoma              \-        Benign           Sebaceous                 3                 C                    70
        B5            15          F        26        Ovary            Mature teratoma              \-        Benign            Apocrine                 3                 C                   100
        B6            16          F        39        Ovary            Mature teratoma              \-        Benign          Endothelium                3                 C                   100
        B6            16          F        39        Ovary            Mature teratoma              \-        Benign          Lymphocytes                3                 N                    70
        B7            17          F        23        Ovary            Mature teratoma              \-        Benign          Lymphocytes                3                 N                    40
        B7            17          F        23        Ovary            Mature teratoma              \-        Benign            Apocrine                2.5                C                    30
        B8            18          F        32        Ovary            Mature teratoma              \-        Benign           Sebaceous                 3                 C                   100
        B8            18          F        32        Ovary            Mature teratoma              \-        Benign              Skin                   3                 C                   100
        B8            18          F        32        Ovary            Mature teratoma              \-        Benign            Thyroid                  3                 C                    80
        B9            19          F        29        Ovary            Mature teratoma              \-        Benign            Thyroid                  3                 C                    80
       B10            20          F        30        Ovary            Mature teratoma              \-        Benign            Follicle                 2                 C                   100
        C1            21          F        40        Ovary            Mature teratoma              \-        Benign           Sebaceous                 3                 C                   100
        C1            21          F        40        Ovary            Mature teratoma              \-        Benign              Skin                  1.5                C                   100
        C2            22          F        35        Ovary            Mature teratoma              \-        Benign           Sebaceous                 3                 C                   100
        C2            22          F        35        Ovary            Mature teratoma              \-        Benign              Skin                   3                 C                   100
        C3            23          F        49        Ovary            Mature teratoma              \-        Benign          Lymphocytes                3                 N                    10
        C4            24          F        51        Ovary            Mature teratoma              \-        Benign              Skin                   3                 C                   100
        C5            25          F        22        Ovary            Mature teratoma              \-        Benign              Skin                   2                 C                   100
        C5            25          F        22        Ovary            Mature teratoma              \-        Benign          Lymphocytes                2                 N                    10
        C6            26          F        69        Ovary            Mature teratoma              \-        Benign               NR                                                            
        C7            27          F        35        Ovary            Mature teratoma              \-        Benign           Sebaceous                 3                 C                   100
        C7            27          F        35        Ovary            Mature teratoma              \-        Benign            Follicle                 2                 C                   100
        C7            27          F        35        Ovary            Mature teratoma              \-        Benign            Apocrine                2.5                C                    90
        C8            28          F         8        Ovary            Mature teratoma              \-        Benign            Apocrine                2.5                M                   100
        C8            28          F         8        Ovary            Mature teratoma              \-        Benign            Apocrine                 1                 C                    50
        C9            29          F        23        Ovary            Mature teratoma              \-        Benign           Sebaceous                 3                 C                   100
        C9            29          F        23        Ovary            Mature teratoma              \-        Benign              Skin                   3                 C                    90
       C10            30          F        26        Ovary            Mature teratoma              \-        Benign               NR                                                            
        D1            31          F        35        Ovary            Mature teratoma              \-        Benign           Sebaceous                 3                 C                   100
        D1            31          F        35        Ovary            Mature teratoma              \-        Benign            Apocrine                 3                 C                    60
        D2            32          F        47        Ovary            Mature teratoma              \-        Benign              Skin                   2                 C                   100
        D2            32          F        47        Ovary            Mature teratoma              \-        Benign           Sebaceous                 3                 C                   100
        D3            33          F        56        Ovary            Mature teratoma              \-        Benign            Adipose                  1                 C                    60
        D3            33          F        56        Ovary            Mature teratoma              \-        Benign            Adipose                  3                 M                    40
        D3            33          F        56        Ovary            Mature teratoma              \-        Benign            Apocrine                 3                 C                    70
        D4            34          F        40        Ovary            Mature teratoma              \-        Benign               NR                                                            
        D5            35          F        32        Ovary            Mature teratoma              \-        Benign              Skin                   3                 C                   100
        D5            35          F        32        Ovary            Mature teratoma              \-        Benign           Sebaceous                 3                 C                   100
        D6            36          F        12        Ovary            Mature teratoma              \-        Benign           Lymphocyte                3                 N                    40
        D6            36          F        12        Ovary            Mature teratoma              \-        Benign            Apocrine                 3                 C                    70
        D7            37          F        43        Ovary            Mature teratoma              \-        Benign               NR                                                            
        D8            38          F        27        Ovary            Mature teratoma              \-        Benign              Skin                   2                 C                   100
        D9            39          F        22        Ovary            Mature teratoma              \-        Benign           Sebaceous                 3                 C                   100
        D9            39          F        22        Ovary            Mature teratoma              \-        Benign            Eccrine                  1                 C                    30
       D10            40          F        40        Ovary            Mature teratoma              \-        Benign            Adipose                  1                 C                    60
       D10            40          F        40        Ovary            Mature teratoma              \-        Benign            Adipose                  3                 M                    30
       D10            40          F        40        Ovary            Mature teratoma              \-        Benign              Skin                   3                 C                   100
        E1            41          F        52        Ovary            Mature teratoma              \-        Benign     Respiratory epithelium         2.5                C                    80
        E2            42          F        23        Ovary            Mature teratoma              \-        Benign           Sebaceous                 3                 C                   100
        E2            42          F        23        Ovary            Mature teratoma              \-        Benign            Thyroid                 1.5                C                    70
        E2            42          F        23        Ovary            Mature teratoma              \-        Benign            Apocrine                 2                 C                    70
        E3            43          F        23        Ovary            Mature teratoma              \-        Benign     Respiratory epithelium          2                 C                    50
        E3            43          F        23        Ovary            Mature teratoma              \-        Benign          Lymphocytes                3                 N                    20
        E4            44          F        47        Ovary            Mature teratoma              \-        Benign              Skin                   3                 C                   100
        E4            44          F        47        Ovary            Mature teratoma              \-        Benign             Nerve                   3                 NM                   80
        E4            44          F        47        Ovary            Mature teratoma              \-        Benign             Nerve                   2                 C                    70
        E5            45          F        45        Ovary            Mature teratoma              \-        Benign              Skin                   3                 C                   100
        E6            46          F        33        Ovary            Mature teratoma              \-        Benign           Sebaceous                 3                 C                   100
        E6            46          F        33        Ovary            Mature teratoma              \-        Benign     Respiratory epithelium         1.5                C                   100
        E6            46          F        33        Ovary            Mature teratoma              \-        Benign            Apocrine                 2                 C                    70
        E6            46          F        33        Ovary            Mature teratoma              \-        Benign          Lymphocytes                3                 N                    5
        E7            47          F        27        Ovary            Mature teratoma              \-        Benign           Sebaceous                2.5                C                   100
        E7            47          F        27        Ovary            Mature teratoma              \-        Benign          Lymphocytes                3                 N                    30
        E7            47          F        27        Ovary            Mature teratoma              \-        Benign              Skin                   2                 C                    90
        E8            48          F        28        Ovary            Mature teratoma              \-        Benign            Adipose                  1                 C                   100
        E8            48          F        28        Ovary            Mature teratoma              \-        Benign            Adipose                  3                 M                    50
        E8            48          F        28        Ovary            Mature teratoma              \-        Benign            Follicle                 3                 C                    90
        E9            49          F        24        Ovary            Mature teratoma              \-        Benign               NR                                                            
       E10            50          F        22        Ovary            Mature teratoma              \-        Benign              Skin                   3                 C                   100
        F1            51          F        27        Ovary     Mature teratoma (ovary tissue)      \-        Benign               NR                                                            
        F2            52          F        32        Ovary            Mature teratoma              \-        Benign          Lymphocytes                3                 N                   100
        F3            53          F        42        Ovary            Mature teratoma              \-        Benign               NR                                                            
        F4            54          F        30        Ovary            Mature teratoma              \-        Benign            Adipose                  1                 C                    30
        F4            54          F        30        Ovary            Mature teratoma              \-        Benign            Adipose                  3                 M                    15
        F5            55          F        38        Ovary            Mature teratoma              \-        Benign           Sebaceous                 3                 C                   100
        F5            55          F        38        Ovary            Mature teratoma              \-        Benign              Skin                  2.5                C                    90
        F5            55          F        38        Ovary            Mature teratoma              \-        Benign          Lymphocytes                3                 N                    10
        F6            56          F        36        Ovary            Mature teratoma              \-        Benign           Sebaceous                 3                 C                   100
        F6            56          F        36        Ovary            Mature teratoma              \-        Benign              Skin                   3                 C                   100
        F7            57          F        25        Ovary            Mature teratoma              \-        Benign              Skin                   3                 C                   100
        F7            57          F        25        Ovary            Mature teratoma              \-        Benign          Lymphocytes                3                 N                    90
        F8            58          F        39        Ovary            Mature teratoma              \-        Benign              Skin                   3                 C                   100
        F8            58          F        39        Ovary            Mature teratoma              \-        Benign           Sebaceous                 3                 C                   100
        F9            59          F        32        Ovary            Mature teratoma              \-        Benign           Sebaceous                 3                 C                   100
        F9            59          F        32        Ovary            Mature teratoma              \-        Benign              Skin                   3                 C                   100
        F9            59          F        32        Ovary            Mature teratoma              \-        Benign            Thyroid                 2.5                C                    50
       F10            60          F        29        Ovary            Mature teratoma              \-        Benign             Nerve                   3                 NM                  100
       F10            60          F        29        Ovary            Mature teratoma              \-        Benign             Nerve                  2.5                C                   100
       F10            60          F        29        Ovary            Mature teratoma              \-        Benign            Adipose                  1                 C                    10
       F10            60          F        29        Ovary            Mature teratoma              \-        Benign            Adipose                  3                 M                    10
       F10            60          F        29        Ovary            Mature teratoma              \-        Benign            Follicle                 2                 C                   100
       F10            60          F        29        Ovary            Mature teratoma              \-        Benign           Sebaceous                 3                 C                   100
        G1            61          F        32        Ovary            Mature teratoma              \-        Benign               NR                                                            
        G2            62          F        36        Ovary            Mature teratoma              \-        Benign            Adipose                  1                 C                    20
        G2            62          F        36        Ovary            Mature teratoma              \-        Benign            Adipose                  3                 M                    10
        G3            63          F        29        Ovary            Mature teratoma              \-        Benign               NR                                                            
        G4            64          F        39        Ovary            Mature teratoma              \-        Benign             Nerve                   3                 NM                   10
        G5            65          F        15        Ovary           Immature teratoma             II       Malignant        Lymphocytes                3                 N                    10
        G6            66          F        40        Ovary           Immature teratoma             \-       Malignant             NR                                                            
        G7            67          F        29        Ovary           Immature teratoma             \-       Malignant          Immature                 3                C/N                   90
        G8            68          F        37        Ovary           Immature teratoma             \-       Malignant          Immature                2.5                C                   100
        G9            69          F        39        Ovary            Mature teratoma              \-        Benign              Skin                   3                 C                   100
       G10            70          F        40        Ovary            Mature teratoma              \-        Benign           Sebaceous                 3                 C                   100
       G10            70          F        40        Ovary            Mature teratoma              \-        Benign              Skin                   3                 C                   100
        H1            71          F        49        Ovary            Mature teratoma              \-        Benign            Adipose                  1                 C                    30
        H1            71          F        49        Ovary            Mature teratoma              \-        Benign            Adipose                  3                 M                    10
        H2            72          F        28        Ovary           Immature teratoma             II       Malignant             NR                                                            
        H3            73          F        37        Ovary           Immature teratoma             \-       Malignant          Immature                 1                 C                    70
        H4            74          F        22        Ovary           Immature teratoma             II       Malignant   Respiratory epithelium          2                 C                    90
        H4            74          F        22        Ovary           Immature teratoma             II       Malignant         Lymphocyte                3                 N                    30
        H5            75          F        28        Ovary           Immature teratoma             II       Malignant          Adipose                  1                 C                   100
        H5            75          F        28        Ovary           Immature teratoma             II       Malignant   Respiratory epithelium         2.5                C                   100
        H5            75          F        28        Ovary           Immature teratoma             II       Malignant         Sebaceous                 1                 C                    70
        H6            76          F        20        Ovary           Immature teratoma             II       Malignant          Immature                1.5                C                    70
        H7            77          F        18        Ovary           Immature teratoma             III      Malignant     Cystic epithelium            1.5                C                    90
        H8            78          M        45        Ovary            Mature teratoma              \-        Benign           Sebaceous                2.5                C                   100
        H8            78          M        45        Ovary            Mature teratoma              \-        Benign          Lymphocytes                3                 N                    50
        H9            79          F        47        Ovary           Malignant teratoma            \-        Benign            Apocrine                1.5                C                    50
       H10            80          F        69        Ovary          Monodermal teratoma            \-       Malignant          Thyroid                 2.5                C                    40
       H10            80          F        69        Ovary          Monodermal teratoma            \-       Malignant        Lymphocytes                3                 N                    30

\* Intensity was graded in the scale from 0 to 3; 0 - no staining, 1 - weak staining, 2 - moderate staining, 3 - strong staining.

\*\* Location of the CX~3~CR1 staining was cytoplasmic (C), nuclear (N), and membranous (M), as indicated.

\*\*\* Percentage of CX~3~CR1-positive cells is indicated.

CX~3~CR1 is expressed in fetal tissues
--------------------------------------

Further we wished to determine CX~3~CR1-positive cells undergoing the normal development. We tested both male and female fetal tissues aged 5 months *in utero*. We found that the majority of epithelial cells, including skin keratinocytes, were CX~3~CR1-positive (Table [2](#T2){ref-type="table"}). Hence, CX~3~CR1-positive skin cells are present not only within abnormally differentiated tissues, such as mature ovarian teratomas, but also in the normally developing skin.

###### 

Expression of CX3CR1 in human fetal tissues

   **Position**   **Number**   **Sex\***   **Age\***     **Organ\***      **Type\***   **Intensity\*\***     **Location**      **Percentage\*\*\***   **Score\*\*\*\***           **Notes**
  -------------- ------------ ----------- ----------- ------------------ ------------ ------------------- ------------------- ---------------------- ------------------- ----------------------------
        A1            1            M        5 mon.          Heart           Normal            2.5                                      100                   250                       
        A2            2            M        5 mon.          Heart           Normal            2.5                                      100                   250                       
        A3            3            M        5 mon.          Heart           Normal            2.5                                      100                   250                       
        A4            4            M        5 mon.       Gallbladder        Normal             2                                       100                   200                       
        A5            5            M        5 mon.       Gallbladder        Normal             2                                        60                   120                       
        A6            6            M        5 mon.       Gallbladder        Normal             2                                        90                   180                       
        A7            7            M        5 mon.          Colon           Normal             3                                       100                   300                       
        A8            8            M        5 mon.          Colon           Normal             3                                       100                   300                       
        A9            9            M        5 mon.          Colon           Normal             3                                       100                   300                       
        B1            10           M        5 mon.     Small intestine      Normal            2.5                                      100                   250                       
        B2            11           M        5 mon.     Small intestine      Normal            2.5                                      100                   250                       
        B3            12           M        5 mon.     Small intestine      Normal            2.5                                      100                   250                       
        B4            13           M        5 mon.          Liver           Normal            2.5                                      100                   250                       
        B5            14           M        5 mon.          Liver           Normal             3                                       100                   300                       
        B6            15           M        5 mon.          Liver           Normal             3                                       100                   300                       
        B7            16           M        5 mon.          Rectum          Normal            2.5                                       95                  237.5                      
        B8            17           M        5 mon.          Rectum          Normal             2                                        95                   190                       
        B9            18           M        5 mon.          Rectum          Normal            2.5                                      100                   250                       
        C1            19           M        5 mon.         Stomach          Normal             2                                        70                   140                       
        C2            20           M        5 mon.         Stomach          Normal            1.5                                       60                   90                        
        C3            21           M        5 mon.         Stomach          Normal            1.5                                       80                   120                       
        C4            22           M        5 mon.      Adrenal gland       Normal            2.5                                       80                   200                       
        C5            23           M        5 mon.      Adrenal gland       Normal             2                                        90                   180                       
        C6            24           M        5 mon.      Adrenal gland       Normal             2                                        60                   120                       
        C7            25           M        5 mon.      Thyroid gland       Normal            0.5                                       30                   15                        
        C8            26           M        5 mon.      Thyroid gland       Normal            0.5                                       10                    5                        
        C9            27           M        5 mon.      Thyroid gland       Normal            0.5                                       10                    5                        
        D1            28           M        5 mon.          Spleen          Normal             1                                        80                   80                        
        D2            29           M        5 mon.          Spleen          Normal             1                                        80                   80                        
        D3            30           M        5 mon.          Spleen          Normal             1                                        80                   80                        
        D4            31           M        5 mon.       Thymus gland       Normal            2.5          Epithelioid cells            20                   50                        
        D4                                                                                     1              Lymphocytes              100                   100                       
        D5            32           M        5 mon.       Thymus gland       Normal            2.5          Epithelioid cells            20                   50                        
        D5                                                                                     1              Lymphocytes              100                   100                       
        D6            33           M        5 mon.       Thymus gland       Normal            2.5          Epithelioid cells            20                   50                        
        D6                                                                                     1              Lymphocytes              100                   100                       
        D7            34           M        5 mon.           Skin           Normal             2              Epithelium                80                   160                       
        D7                                                                                     3                Adipose                 70                   210                       
        D8            35           M        5 mon.           Skin           Normal            1.5             Epithelium                80                   120                       
        D8                                                                                     3                Adipose                 70                   210                       
        D9            36           M        5 mon.           Skin           Normal             2              Epithelium                90                   180                       
        D9                                                                                     3                Adipose                 80                   240                       
        E1            37           M        5 mon.           Bone           Normal            2.5                                       30                   75                        
        E2            38           M        5 mon.           Bone           Normal            2.5                                       30                   75                        
        E3            39           M        5 mon.           Bone           Normal            2.5                                       30                   75                        
        E4            40           M        5 mon.        Epididymis        Normal             1                                        90                   90                        
        E5            41           M        5 mon.        Epididymis        Normal            0.5                                       60                   30                        
        E6            42           M        5 mon.        Epididymis        Normal            0.5                                       70                   35                        
        E7            43           M        5 mon.          Brain           Normal             2                                        20                   40                        
        E8            44           M        5 mon.          Brain           Normal             1                                        5                     5                        
        E9            45           M        5 mon.          Brain           Normal             1                                        5                     5                        
        F1            46           M        5 mon.     Lung and trachea     Normal             3                Trachea                 90                   270                       
        F1            46           M        5 mon.     Lung and trachea     Normal             3                Alveoli                 25                   75                        
        F2            47           M        5 mon.     Lung and trachea     Normal             3                Trachea                 90                   270                       
        F2            47           M        5 mon.     Lung and trachea     Normal             1                Alveoli                 25                   25                        
        F3            48           M        5 mon.     Lung and trachea     Normal             3                Trachea                 80                   240                       
        F3            48           M        5 mon.     Lung and trachea     Normal             1                Alveoli                 25                   25                        
        F4            49           M        5 mon.          Muscle          Normal            0.5                                      100                   50                        
        F5            50           M        5 mon.          Muscle          Normal            0.5                                      100                   50                        
        F6            51           M        5 mon.          Muscle          Normal            0.5                                      100                   50                        
        F7            52           M        5 mon.      Smooth muscle       Normal             2                                       100                   200                       
        F8            53           M        5 mon.      Smooth muscle       Normal             2                                       100                   200                       
        F9            54           M        5 mon.      Smooth muscle       Normal             2                                       100                   200                       
        G1            55           M        5 mon.          Kidney          Normal             2                Tubules                 80                   160                       
        G1            55           M        5 mon.          Kidney          Normal             1               Glomeruli                50                   50                        
        G2            56           M        5 mon.          Kidney          Normal            2.5               Tubules                 70                   175                       
        G2            56           M        5 mon.          Kidney          Normal            0.5              Glomeruli                30                   15                        
        G3            57           M        5 mon.          Kidney          Normal            1.5               Tubules                 90                   135                       
        G3            57           M        5 mon.          Kidney          Normal            0.5              Glomeruli                70                   35                        
        G4            58           M        5 mon.           Eye            Normal             3                                       100                   300          Retinal pigment epithelium
        G5            59           M        5 mon.           Eye            Normal             3                                       100                   300          Retinal pigment epithelium
        G6            60           M        5 mon.           Eye            Normal             3                                       100                   300          Retinal pigment epithelium
        G7            61           F        5 mon.      Umbilical cord      Normal             2                                       100                   200                       
        G8            62           F        5 mon.      Umbilical cord      Normal            1.5                                      100                   150                       
        G9            63           F        5 mon.      Umbilical cord      Normal            NA                                        NA                   NA                        
        H1            64           F        5 mon.         Placenta         Normal            0.5                                       20                   10                        
        H2            65           F        5 mon.         Placenta         Normal            0.5                                       10                    5                        
        H3            66           F        5 mon.         Placenta         Normal            0.5                                       40                   20                        
        H4            67           F        5 mon.          Uterus          Normal            0.5                                       20                   10                        
        H5            68           F        5 mon.          Uterus          Normal            0.5                                       5                    2.5                       
        H6            69           F        5 mon.          Uterus          Normal            0.5                                       20                   10                        
        H7            70           F        5 mon.         Pancreas         Normal             2            Acini and ducts             80                   160                       
        H8            71           F        5 mon.         Pancreas         Normal            2.5           Acini and ducts             80                   200                       
        H9            72           F        5 mon.         Pancreas         Normal            2.5           Acini and ducts             70                   175                       
        I1            73           F        5 mon.          Ovary           Normal             3                                        70                   210                       
        I2            74           F        5 mon.          Ovary           Normal             3                                        80                   240                       
        I3            75           F        5 mon.          Ovary           Normal             3                                        90                   270                       
        I4            76           F        5 mon.      Fallopian tube      Normal            0.5                                       5                    2.5                       
        I5            77           F        5 mon.      Fallopian tube      Normal             1                                        10                   10                        
        I6            78           F        5 mon.      Fallopian tube      Normal            1.5                                       5                    7.5                       

\* Information obtained from the manufacturer (US Biomax; Rockville, MD) for the multiple organ fetal tissue array BE01014; TMA contained triplicate cores (26cases/78cores).

\*\* Intensity of staining was scored as negative (0), weak positive (1), moderate positive (2), and strong positive (3).

\*\*\* Denotes percentage of positive cells in the core.

\*\*\*\* Score has been calculated as intensity multiplied by percentage of positive cells.

CX~3~CR1 is required for keratinocyte differentiation
-----------------------------------------------------

Based on our observations regarding CX~3~CR1 expression in both normally and abnormally developing keratinocytes, we hypothesized that CX~3~CR1 may be important for cell differentiation into the epidermal lineage. Thus, we tested the requirement for CX~3~CR1 in keratinocyte differentiation using a cell culture model. Ovarian teratocarcinoma cell line PA-1 has been established from the ascites of a patient with malignant ovarian teratoma \[[@B16]\]. Chromosomal analysis had suggested that these cells have a heterozygous origin and derived at a stage prior to the first meiotic division \[[@B17]\]. Several studies have shown that PA-1 is capable of differentiation into diverse cell lineages at the appropriate culture conditions \[[@B16],[@B18],[@B19]\]. Based on many similarities between the teratocarcinoma cells and early embryonic cells, the former has been used to study processes of differentiation \[[@B19],[@B20]\]. Using gene specific shRNA constructs, we downregulated CX~3~CR1 in PA-1 cell line (Figure [2](#F2){ref-type="fig"}A). Further we cultured both CX~3~CR1sh-PA-1 and the control cells transfected with a scrambled shRNA construct on Matrigel in the presence and absence of 0.5 nM BMP-4 for 2 weeks. Expression of cytokeratin 14 (CK14) and cytokeratin 18 (CK18) was analysed with immunofluorescence microscopy and Western blotting (Figure [2](#F2){ref-type="fig"}B,C). We observed that only PA-1 transfected with scrambled shRNA and cultured in BMP-4-supplemented media expressed significantly higher levels of CK14 compared to scrambled shRNA PA-1 or CX~3~CR1 shRNA PA-1cultured in the absence of BMP-4, as well as CX~3~CR1 shRNA PA-1 cultured in the presence of BMP-4 (Figure [2](#F2){ref-type="fig"}B,C). In opposite, scrambled shRNA PA-1 or CX~3~CR1 shRNA PA-1cultured in the absence of BMP-4, as well as CX~3~CR1 shRNA PA-1 cultured in the presence of BMP-4 expressed higher levels of CK18 compared to scrambled shRNA PA-1 cultured in the presence of BMP-4 (Figure [2](#F2){ref-type="fig"}C). PA-1 expressed fractalkine ligand (CX~3~CL1) necessary for the receptor (CX~3~CR1) activation (Figure [2](#F2){ref-type="fig"}D). These data suggest that CX~3~CR1-positive PA-1 cells are able to proceed toward differentiation into skin keratinocytes in the presence of BMP-4 and begin expressing a marker of stratified epithelium CK14, while the loss of CX~3~CR1 restricts differentiation and the cells remain CK18-positive simple-epithelial cells.

![**CX**~**3**~**CR1 is required for keratinocytes differentiation. (A)** Expression of CX~3~CR1 in parental PA-1 cell line and that stably transfected with either CX~3~CR1 or scrambled shRNA constructs was examined with Western blot. Actin served as a loading control. CX~3~CR1 expression levels were quantified using digital densitometry and normalized to the levels of actin expression. **(B)** Expression of cytokeratin 14 in PA-1 cells stably transfected with either CX~3~CR1 or scrambled shRNA constructs treated with recombinant BMP-4 or vehicle, as indicated, was examined with immunocytochemistry. CK14 in PA-1 was probed with anti-CK14 and Alexa555-conjugated anti-rabbit antibodies, and DNA was stained with 4',6-Diamidino-2-Phenylindole, Dihydrochloride (DAPI); CK14 -- red, DNA -- blue. Images were taken using 5× magnification on the objective. The histogram demonstrates the average intensity of CK14 signal across the field as determined by the Zeiss AxioVision software. Data is an average of three independent experiments. \**p* \< 0.05. **(C)** Expression of cytokeratins 14 and 18 in PA-1 cells stably transfected with either CX~3~CR1 or scrambled shRNA constructs treated with recombinant BMP-4 or vehicle, as indicated, was examined with Western blot. β-Tubulin served as a loading control. The histogram shows CK14 and CK18 expression levels. Expression of CK18 in CX~3~CR1shRNA-transfected PA-1 cells was arbitrarily set as 1 and expression of both CK14 and CK18 in other conditions was calculated accordingly. The data represent a typical Western blot image, and quantitative analysis was performed using three independently performed experiments. \**p* \< 0.05. **(D)** Expression of CX~3~CL1 in SKOV-3 and PA-1 cell lines was examined with Western blot. Actin served as a loading control. SKOV-3 cell line was used as a positive control.](1757-2215-6-57-2){#F2}

Discussion
==========

Our findings demonstrate that cells of the skin lineage comprise the most predominant CX~3~CR1-positive cell type within the specimens of ovarian teratoma. Mature skin is a predominant tissue found in mature ovarian teratomas \[[@B21]\]. Our findings also show that normally developed keratinocytes are CX~3~CR1-positive. Importantly, our findings suggest that CX~3~CR1 could be an important player in keratinocyte differentiation. Our data indicate that teratocarcinoma cell line PA-1 expressed a basal keratinocyte marker CK14 when cultured on Matrigel in the presence of BMP-4. In opposite, cells with silenced CX~3~CR1 and those cultured in the absence of BMP-4 expressed CK18 specific for simple non-stratified epithelium.

The role for CX~3~CR1 in skin differentiation has not been described before, although, the role of this receptor in skin wound healing has been reported \[[@B22]\]. Our findings could be potentially important, as skin is the largest organ of the human body. Many pathological conditions and injuries require regeneration of the skin, and affecting the CX~3~CR1-dependent pathway could be one way to achieving faster skin formation from cells capable of differentiation. Thus, the studies of the role of CX~3~CR1 in keratinocyte differentiation need to be expanded further to include more extensive studies on other abnormally differentiating teratoma cell lines, as well as normally differentiating embryonic stem cells. Furthermore, we observed that CX3CR1 is expressed in other developing tissues, as indicated in Table [2](#T2){ref-type="table"}, thus, it is possible that this receptor could be important for the development of those tissues as well. In fact, a role for the fractalkine axis in osteoclasts differentiation has been reported, whereby CX~3~CL1-expressing osteoblasts regulate differentiation of CX~3~CR1-positive osteoclast precursors \[[@B12]\]. Hence, more rigorous future studies of the role of CX~3~CR1 in development and differentiation are required.

Conclusions
===========

Here we present that fractalkine receptor is expressed by skin cells in specimens of human ovarian teratoma and fetus and is required for epidermal lineage differentiation. This information sheds light on the ovarian pathology, dermoid cyst, and outlines possible mechanisms of cell differentiation within this benign formation. As the fractalkine receptor has recently emerged as a novel potential therapeutic target against many debilitating diseases, it is important to remember its role in cell differentiation when applying future anti-fractalkine therapies.
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